{"id":"W4393257410","doi":"10.3138/cim-2024-2569","title":"Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada","year":2024,"lang":"en","type":"review","venue":"Clinical and investigative medicine","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland; Centre Hospitalier de l’Université de Montréal; University of British Columbia; University of Ottawa; St. Michael's Hospital; University of Toronto; Western University; Nova Scotia Health Authority; Saskatchewan Health Authority; Saskatchewan Health; University Health Network; University of Saskatchewan; University of Alberta; McMaster University","funders":"","keywords":"Medicine; Romiplostim; Rituximab; Splenectomy; Thrombopoietin; Immune thrombocytopenia; Internal medicine; Immunology; Antibody; Platelet","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00254983,0.0008497431,0.002222832,0.01038162,0.001277435,0.002818553,0.001296888,0.001201103,0.005683594],"category_scores_gemma":[0.01062331,0.0004320389,0.001923468,0.02041448,0.0008895971,0.001153255,0.0009731631,0.001141412,0.0003451257],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02247714,"about_ca_system_score_gemma":0.09658898,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6501222,"about_ca_topic_score_gemma":0.8239195,"domain_scores_codex":[0.9978952,0.0003568073,0.000556956,0.0001693299,0.0008038118,0.0002178487],"domain_scores_gemma":[0.9892982,0.004847011,0.00171611,0.00008472468,0.003612898,0.0004410027],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000306581,0.00004409799,0.003229099,0.5537129,0.001449389,0.0008004332,0.0008980744,0.0006283747,0.0004176107,0.004812347,0.06471585,0.3689853],"study_design_scores_gemma":[0.0001519468,0.0001050101,0.01240618,0.520337,0.005852711,0.001298432,0.0008744907,0.0002486151,0.000242915,0.0007788202,0.4576272,0.00007672647],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002542069,0.9976758,0.00002697188,0.0007595756,0.00008041702,0.00002153649,0.0002713963,0.000002976961,0.0009070484],"genre_scores_gemma":[0.003134481,0.9958302,0.0001305927,0.0005454693,0.00004753239,0.00002741023,0.0001381042,0.000001740754,0.0001443564],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.3498778,"threshold_uncertainty_score":0.7038765,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1769314969988618,"score_gpt":0.4192719638517409,"score_spread":0.2423404668528792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}